Mammalian cell cycle checkpoints: Signalling pathways and their organization in space and time

DNA Repair

Volumn 3, Issue 8-9, 2004, Pages 997-1007

  Lukas, Jiri ^a   Lukas, Claudia ^a   Bartek, Jiri ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Checkpoint proteins; Mammalian cell cycle; Signalling pathways

Indexed keywords

CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CELL NUCLEUS; CHROMOSOME; DNA DAMAGE; GENE DUPLICATION; GENOTOXICITY; HUMAN; MAMMAL CELL; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL NUCLEUS; DNA; DNA DAMAGE; DNA REPAIR; G1 PHASE; G2 PHASE; GENOME; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; S PHASE; SIGNAL TRANSDUCTION; TIME FACTORS;

MAMMALIA;

EID: 3242890575     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2004.03.006     Document Type: Review

References (97)

1. Zhou B.B., Elledge S.J. The DNA damage response: putting checkpoints in perspective. Nature. 408:2000;433-439
2. Nyberg K.A., Michelson R.J., Putnam C.W., Weinert T.A. Toward maintaining the genome: DNA damage and replication checkpoints. Annu. Rev. Genet. 36:2002;617-656
3. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer. 3:2003;155-168
4. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15:2001;2177-2196
5. Melo J., Toczyski D. A unified view of the DNA-damage checkpoint. Curr. Opin. Cell Biol. 14:2002;237-245
6. Petrini J.H., Stracker T.H. The cellular response to DNA double-strand breaks: defining the sensors and mediators. Trends Cell Biol. 13:2003;458-462
7. Bartek J., Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 3:2003;421-429
8. Donzelli M., Draetta G.F. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep. 4:2003;671-677
9. Pandita T.K., Lieberman H.B., Lim D.S., Dhar S., Zheng W., Taya Y., Kastan M.B. Ionizing radiation activates the ATM kinase throughout the cell cycle. Oncogene. 19:2000;1386-1391
10. Lukas C., Bartkova J., Latella L., Falck J., Mailand N., Schroeder T., Sehested M., Lukas J., Bartek J. DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. Cancer Res. 61:2001;4990-4993
11. Jin Y., Xu X.L., Yang M.C., Wei F., Ayi T.C., Bowcock A.M., Baer R. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12075-12080
12. Kaneko Y.S., Watanabe N., Morisaki H., Akita H., Fujimoto A., Tominaga K., Terasawa M., Tachibana A., Ikeda K., Nakanishi M., Kaneko Y. Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase. Oncogene. 18:1999;3673-3681
13. Bartek J., Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett. 490:2001;117-122
14. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1999;1501-1512
15. Donzelli M., Squatrito M., Ganoth D., Hershko A., Pagano M., Draetta G.F. Dual mode of degradation of Cdc25 A phosphatase. EMBO J. 21:2002;4875-4884
16. Bartek J., Lukas J. Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell Biol. 13:2001;738-747
17. Sorensen C.S., Syljuasen R.G., Falck J., Schroeder T., Ronnstrand L., Khanna K.K., Zhou B.B., Bartek J., Lukas J. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell. 3:2003;247-258
18. Zhao H., Watkins J.L., Piwnica-Worms H. Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc. Natl. Acad. Sci. U.S.A. 99:2002;14795-14800
19. Mailand N., Falck J., Lukas C., Syljuasen R.G., Welcker M., Bartek J., Lukas J. Rapid destruction of human Cdc25A in response to DNA damage. Science. 288:2000;1425-1429
20. Falck J., Mailand N., Syljuasen R.G., Bartek J., Lukas J. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature. 410:2001;842-847
21. Falck J., Petrini J.H., Williams B.R., Lukas J., Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat. Genet. 30:2002;290-294
22. Busino L., Donzelli M., Chiesa M., Guardavaccaro D., Ganoth D., Dorrello N.V., Hershko A., Pagano M., Draetta G.F. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature. 426:2003;87-91
23. Jin J., Shirogane T., Xu L., Nalepa G., Qin J., Elledge S.J., Harper J.W. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17:2003;3062-3074
24. Harbour J.W., Dean D.C. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14:2000;2393-2409
25. Gottifredi V., Karni-Schmidt O., Shieh S.S., Prives C. p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Mol. Cell. Biol. 21:2001;1066-1076
26. Ren B., Cam H., Takahashi Y., Volkert T., Terragni J., Young R.A., Dynlacht B.D. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 16:2002;245-256
27. Molinari M., Mercurio C., Dominguez J., Goubin F., Draetta G.F. Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep. 1:2000;71-79
28. Wahl G.M., Carr A.M. The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat. Cell Biol. 3:2001;E277-286
29. Khosravi R., Maya R., Gottlieb T., Oren M., Shiloh Y., Shkedy D. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 96:1999;14973-14977
30. Maya R., Balass M., Kim S.T., Shkedy D., Leal J.F., Shifman O., Moas M., Buschmann T., Ronai Z., Shiloh Y., Kastan M.B., Katzir E., Oren M. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15:2001;1067-1077
31. Dornan D., Shimizu H., Burch L., Smith A.J., Hupp T.R. The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53. Mol. Cell. Biol. 23:2003;8846-8861
32. Harrington E.A., Bruce J.L., Harlow E., Dyson N. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc. Natl. Acad. Sci. U.S.A. 95:1998;11945-11950
33. Niculescu A.B. 3rd, Chen X., Smeets M., Hengst L., Prives C., Reed S.I. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18:1998;629-643
34. Knudsen K.E., Booth D., Naderi S., Sever-Chroneos Z., Fribourg A.F., Hunton I.C., Feramisco J.R., Wang J.Y., Knudsen E.S. RB-dependent S-phase response to DNA damage. Mol. Cell. Biol. 20:2000;7751-7763
35. Avni D., Yang H., Martelli F., Hofmann F., ElShamy W.M., Ganesan S., Scully R., Livingston D.M. Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage. Mol. Cell. 12:2003;735-746
36. Bartek J., Bartkova J., Lukas J. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8:1996;805-814
37. Craig A., Scott M., Burch L., Smith G., Ball K., Hupp T. Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain. EMBO Rep. 4:2003;787-792
38. Takai H., Smogorzewska A., de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13:2003;1549-1556
39. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 426:2003;194-198
40. Maser R.S., DePinho R.A. Connecting chromosomes, crisis, and cancer. Science. 297:2002;565-569
41. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421:2003;499-506
42. Zou L., Elledge S.J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science. 300:2003;1542-1548
43. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22:2003;5612-5621
44. Z. Horejsi, J. Falck, C.J. Bakkenist, M.B. Kastan, J. Lukas, J. Bartek, Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation, Oncogene 23 (2004) 3123-3128.
45. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., Weitzman M.D. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22:2003;6610-6620
46. Mochan T.A., Venere M., DiTullio R.A. Jr., Halazonetis T.D. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res. 63:2003;8586-8591
47. Costanzo V., Robertson K., Ying C.Y., Kim E., Avvedimento E., Gottesman M., Grieco D., Gautier J. Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage. Mol. Cell. 6:2000;649-659
48. Painter R.B., Young B.R. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl. Acad. Sci. U.S.A. 77:1980;7315-7317
49. D'Amours D., Jackson S.P. The Mre11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat. Rev. Mol. Cell. Biol. 3:2002;317-327
50. Mirzoeva O.K., Petrini J.H. DNA damage-dependent nuclear dynamics of the Mre11 complex. Mol. Cell. Biol. 21:2001;281-288
51. Lukas C., Falck J., Bartkova J., Bartek J., Lukas J. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat. Cell Biol. 5:2003;255-260
52. Celeste A., Fernandez-Capetillo O., Kruhlak M.J., Pilch D.R., Staudt D.W., Lee A., Bonner R.F., Bonner W.M., Nussenzweig A. Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks. Nat. Cell Biol. 5:2003;675-679
53. Kim S.T., Xu B., Kastan M.B. Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev. 16:2002;560-570
54. Yazdi P.T., Wang Y., Zhao S., Patel N., Lee E.Y., Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev. 16:2002;571-582
55. Xu B., Kim S., Kastan M.B. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21:2001;3445-3450
56. Wang B., Matsuoka S., Carpenter P.B., Elledge S.J. 53BP1, a mediator of the DNA damage checkpoint. Science. 298:2002;1435-1438
57. Nakanishi K., Taniguchi T., Ranganathan V., New H.V., Moreau L.A., Stotsky M., Mathew C.G., Kastan M.B., Weaver D.T., D'Andrea A.D. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat. Cell Biol. 4:2002;913-920
58. Costanzo V., Shechter D., Lupardus P.J., Cimprich K.A., Gottesman M., Gautier J. An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol. Cell. 11:2003;203-213
59. Groth A., Lukas J., Nigg E.A., Sillje H.H., Wernstedt C., Bartek J., Hansen K. Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint. EMBO J. 22:2003;1676-1687
60. Krause D.R., Jonnalagadda J.C., Gatei M.H., Sillje H.H., Zhou B.B., Nigg E.A., Khanna K. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1. Oncogene. 22:2003;5927-5937
61. Mailand N., Podtelejnikov A.V., Groth A., Mann M., Bartek J., Lukas J. Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J. 21:2002;5911-5920
62. Xiao Z., Chen Z., Gunasekera A.H., Sowin T.J., Rosenberg S.H., Fesik S., Zhang H. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. J. Biol. Chem. 278:2003;21767-21773
63. Bulavin D.V., Higashimoto Y., Popoff I.J., Gaarde W.A., Basrur V., Potapova O., Appella E., Fornace A.J. Jr. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature. 411:2001;102-107
64. Forrest A., Gabrielli B. Cdc25B activity is regulated by 14-3-3. Oncogene. 20:2001;4393-4401
65. DiTullio R.A. Jr., Mochan T.A., Venere M., Bartkova J., Sehested M., Bartek J., Halazonetis T.D. 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat. Cell Biol. 4:2002;998-1002
66. Fernandez-Capetillo O., Chen H.T., Celeste A., Ward I., Romanienko P.J., Morales J.C., Naka K., Xia Z., Camerini-Otero R.D., Motoyama N., Carpenter P.B., Bonner W.M., Chen J., Nussenzweig A. DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat. Cell Biol. 4:2002;993-997
67. Taylor W.R., Stark G.R. Regulation of the G2/M transition by p53. Oncogene. 20:2001;1803-1815
68. B.-B. Zhou, J. Bartek, Targeting CHKs: cemosenzitization versus Chemoprotection, Nat. Rev. Cancer 4 (2004) 216-225.
69. Zhang J., Campbell R.E., Ting A.Y., Tsien R.Y. Creating new fluorescent probes for cell biology. Nat. Rev. Mol. Cell. Biol. 3:2002;906-918
70. Lippincott-Schwartz J., Patterson G.H. Development and use of fluorescent protein markers in living cells. Science. 300:2003;87-91
71. J. Lippincott-Schwartz, N. Altan-Bonnet, G.H. Patterson, Photobleaching and photoactivation: following protein dynamics in living cells, Nat. Cell. Biol. (Suppl.) (2003) S7-S14.
72. Rademakers S., Volker M., Hoogstraten D., Nigg A.L., Mone M.J., Van Zeeland A.A., Hoeijmakers J.H., Houtsmuller A.B., Vermeulen W. Xeroderma pigmentosum group A protein loads as a separate factor onto DNA lesions. Mol. Cell. Biol. 23:2003;5755-5767
73. D. Gerlich, J. Ellenberg, 4D imaging to assay complex dynamics in live specimens, Nat. Cell. Biol. (Suppl) (2003) S14-S19.
74. Stephens D.J., Allan V.J. Light microscopy techniques for live cell imaging. Science. 300:2003;82-86
75. Phair R.D., Misteli T. Kinetic modelling approaches to in vivo imaging. Nat. Rev. Mol. Cell. Biol. 2:2001;898-907
76. Rouse J., Jackson S.P. Interfaces between the detection, signaling, and repair of DNA damage. Science. 297:2002;547-551
77. Rogakou E.P., Boon C., Redon C., Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell. Biol. 146:1999;905-916
78. Houtsmuller A.B., Rademakers S., Nigg A.L., Hoogstraten D., Hoeijmakers J.H., Vermeulen W. Action of DNA repair endonuclease ERCC1/XPF in living cells. Science. 284:1999;958-961
79. Hoogstraten D., Nigg A.L., Heath H., Mullenders L.H., van Driel R., Hoeijmakers J.H., Vermeulen W., Houtsmuller A.B. Rapid switching of TFIIH between RNA polymerase I and II transcription and DNA repair in vivo. Mol. Cell. 10:2002;1163-1174
80. Volker M., Mone M.J., Karmakar P., van Hoffen A., Schul W., Vermeulen W., Hoeijmakers J.H., van Driel R., van Zeeland A.A., Mullenders L.H. Sequential assembly of the nucleotide excision repair factors in vivo. Mol. Cell. 8:2001;213-224
81. Essers J., Houtsmuller A.B., van Veelen L., Paulusma C., Nigg A.L., Pastink A., Vermeulen W., Hoeijmakers J.H., Kanaar R. Nuclear dynamics of RAD52 group homologous recombination proteins in response to DNA damage. EMBO J. 21:2002;2030-2037
82. Carney J.P., Maser R.S., Olivares H., Davis E.M., Le Beau M., Yates J.R. 3rd, Hays L., Morgan W.F., Petrini J.H. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell. 93:1998;477-486
83. Zhu X.D., Kuster B., Mann M., Petrini J.H., de Lange T. Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat. Genet. 25:2000;347-352
84. Wu G., Lee W.H., Chen P.L. NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem. 275:2000;30618-30622
85. Wu G., Jiang X., Lee W.H., Chen P.L. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1. Cancer Res. 63:2003;2589-2595
86. Carbone R., Pearson M., Minucci S., Pelicci P.G. PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage. Oncogene. 21:2002;1633-1640
87. Mirzoeva O.K., Petrini J.H. DNA replication-dependent nuclear dynamics of the Mre11 complex. Mol. Cancer Res. 1:2003;207-218
88. Limoli C.L., Ward J.F. A new method for introducing double-strand breaks into cellular DNA. Radiat. Res. 134:1993;160-169
89. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10:2000;886-895
90. Tashiro S., Walter J., Shinohara A., Kamada N., Cremer T. Rad51 accumulation at sites of DNA damage and in post-replicative chromatin. J. Cell Biol. 150:2000;283-291
91. Kobayashi J., Tauchi H., Sakamoto S., Nakamura A., Morishima K., Matsuura S., Kobayashi T., Tamai K., Tanimoto K., Komatsu K. NBS1 localizes to gamma-H2AX foci through interaction with the FHA/BRCT domain. Curr. Biol. 12:2002;1846-1851
92. Goldberg M., Stucki M., Falck J., D'Amours D., Rahman D., Pappin D., Bartek J., Jackson S.P. MDC1 is required for the intra-S-phase DNA damage checkpoint. Nature. 421:2003;952-956
93. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature. 421:2003;961-966
94. Xu X., Stern D.F. NFBD1/KIAA0170 is a chromatin-associated protein involved in DNA damage signaling pathways. J. Biol. Chem. 278:2003;8795-8803
95. Green C.M., Almouzni G. Local action of the chromatin assembly factor CAF-1 at sites of nucleotide excision repair in vivo. EMBO J. 22:2003;5163-5174
96. Verveer P.J., Wouters F.S., Reynolds A.R., Bastiaens P.I. Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. Science. 290:2000;1567-1570
97. Yu X., Chini C.C., He M., Mer G., Chen J. The BRCT domain in a phospho-protein binding domain. Science. 302:2003;639-642